Thus, we propose that GCS inhibition constitutes a potential target for protecting neurons from ADDL-mediated neurotoxicity and insulin resistance in Alzheimer’s disease. The gene discussed is UGCG; the disease is early-onset autosomal dominant Alzheimer disease.